OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 03/16/2026 at 18:00, 4 months 21 days ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verhoogt totaal aantal gewone aandelen naar 88.691.312

Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Converteerbare Obligaties
PRESS RELEASE

published on 03/16/2026 at 18:00, 4 months 21 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 bonds in Oxurion, resulting in EUR 100,000 capital increase. Oxurion issues 18.59M new shares as part of a EUR 20M Capital Commitment agreement with Atlas

Convertible Bonds Capital Increase Share Issuance Atlas Special Opportunities Oxurion
BRIEF

published on 03/10/2026 at 18:35, 4 months 27 days ago

Oxurion étend son programme de financement avec Atlas Special Opportunities

Obligations Convertibles Capitalisation Boursière Financement D'Oxurion Accord Atlas Échéance De L'obligation
BRIEF

published on 03/10/2026 at 18:35, 4 months 27 days ago

Oxurion Extends Financing Program with Atlas Special Opportunities

Convertible Bonds Market Capitalization Oxurion Financing Atlas Agreement Bond Maturity
BRIEF

published on 03/10/2026 at 18:35, 4 months 27 days ago

Oxurion prolonge son programme de financement jusqu'à 2027

Financement Obligations Convertibles Capitalisation Boursière Oxurion Prolongation
BRIEF

published on 03/10/2026 at 18:35, 4 months 27 days ago

Oxurion extends its financing program until 2027

Convertible Bonds Funding Extension Market Capitalization Oxurion
PRESS RELEASE

published on 03/10/2026 at 18:30, 4 months 27 days ago

Oxurion verlengt haar financieringsprogramma
Oxurion NV, ein belgisches Biofarmazieunternehmen, verlängert und modifiziert das Finanzierungsprogramm mit Atlas Special Opportunities II, LLC

Finanzierung Oxurion Belgien Atlas Special Opportunities II, LLC Biofarmazie
PRESS RELEASE

published on 03/10/2026 at 18:30, 4 months 27 days ago

Oxurion prolonge son programme de financement
Oxurion NV prolonge son programme de financement d'obligations convertibles avec Atlas Special Opportunities II, LLC jusqu'au 2 mars 2027 et ajuste les conditions de financement

Financement Obligations Convertibles Avenant Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE

published on 03/10/2026 at 18:30, 4 months 27 days ago

Oxurion Extends Its Financing Program
Oxurion NV extends financing program with Atlas Special Opportunities II, LLC. Amendments include 12-month extension, adjusted maturity terms, and right to transfer bonds internationally

Biopharmaceutical Company Oxurion NV Financing Program Atlas Special Opportunities II LLC Bond Subscription Agreement
BRIEF

published on 02/27/2026 at 18:05, 5 months 7 days ago

Oxurion continues discussions for the acquisition of a French CRO

Acquisition Pharmaceutical Due Diligence Oxurion French CRO

Published on 08/07/2026 at 13:00, 54 minutes ago

Gold Terra Announces Start of Drilling on the Campbell Shear Northern Zone 103N Extension to Expand 2026 MRE of Inferred 595,000 Ounces, Con Mine, Yellowknife, NWT
Published on 08/07/2026 at 00:45, 13 hours 9 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 14 hours 39 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 15 hours 39 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 15 hours 49 minutes ago

Innodata Reports Record Second Quarter 2026 Results

View all ACCESSWIRE

Published on 08/07/2026 at 13:30, 24 minutes ago

Alphawave: New NC 6.1 Trading Model Starts Q3 2026 with +19.36%
Published on 08/07/2026 at 12:05, 1 hour 48 minutes ago

Genel Energy PLC: Response to announcement made by DNO ASA
Published on 08/07/2026 at 11:12, 2 hours 42 minutes ago

EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
Published on 08/07/2026 at 11:00, 2 hours 54 minutes ago

MuniFin Group’s Half Year Report January–June 2026 is published
Published on 08/07/2026 at 11:00, 2 hours 54 minutes ago

PWO Group generates new business of EUR 363m and increases free cash flow in the first half of 2026

View all EQS

Published on 08/07/2026 at 08:30, 5 hours 24 minutes ago

Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 5 hours 24 minutes ago

Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 19 hours 28 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 19 hours 28 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 20 hours 8 minutes ago

Déclaration des droits de vote à fin juillet 2026

View all LES ECHOS COMFI WIRE

News